Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5669)
All Articles published online
|
Publishing Process of This Article
|
Nov 15, 2020 (publication date) through Nov 5, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cigrovski Berkovic M, Bilic-Curcic I, Bozek T, Herman Mahecic D, Klobucar Majanovic S, Canecki-Varzic S, Andric J, Marusic S, Mrzljak A. Glucagon-like-1 receptor agonists and sodium/glucose cotransporter-2 inhibitors combination—are we exploiting their full potential in a real life setting? World J Diabetes 2020; 11(11): 540-552 [PMID: 33269065 DOI: 10.4239/wjd.v11.i11.540] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v11/i11/540.htm |
| Number | Citing Articles |
| 1 |
Aftab Ahmad, Hani Sabbour. Effectiveness and safety of the combination of sodium–glucose transport protein 2 inhibitors and glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of observational studies. Cardiovascular Diabetology 2024; 23(1) doi: 10.1186/s12933-024-02192-4
|
| 2 |
Rongjing Song, Qiaoyu Hou, Xiuying Zhang, Wei Zhao, Gang Liu, Meng Li, Xiaohong Zhang, Linong Ji. Retrospective analysis of the effect of SGLT-2 inhibitors on renal function in patients with type 2 diabetes in the real world. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1376850
|
| 3 |
Pierre Gourdy, Patrice Darmon, François Dievart, Jean-Michel Halimi, Bruno Guerci. Combining glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) in patients with type 2 diabetes mellitus (T2DM). Cardiovascular Diabetology 2023; 22(1) doi: 10.1186/s12933-023-01798-4
|
| 4 |
Stanley S. Schwartz, Mary E. Herman. Gluco-regulation & type 2 diabetes: entrenched misconceptions updated to new governing principles for gold standard management. Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1394805
|